Asymptomatic HIV testing in Rossano Veneto

Find health labs to test for Asymptomatic HIV in Rossano Veneto and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Capitan Alessio, 20/D 36027 Rosà (VI)

2.3 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via dell’industria, 4 Cittadella c/o Polimedica Fisiohome 35013 Cittadella (PD)

4 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Enrico Fermi 1/B 31030 Castello di Godego (TV)

4 km

Unverified

See Details

HIV Test by Laboratorio Lifebrain

Via Giuseppe Verdi, 16 36022 Cassola (VI)

1.9 km

Unverified

See Details

HIV Test by Laboratorio Lifebrain

Viale Vicenza, 55 36061 Bassano del Grappa (VI)

5.3 km

Unverified

See Details

Rapid HIV Test by Crabion S.R.L.

Via Amilcare Ponchielli, 8, 31033 Castelfranco Veneto TV, Italia

6.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

P.zza Europa Unita, 75 31033 Castelfranco Veneto (TV)

6.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Fermi 1 36063 Marostica (VI)

7.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Roma, 323/A 35010 San Giorgio delle Pertiche (PD)

12.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Roma, 73 35012 Borgoricco (PD)

14.4 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.